These stocks are usually going up or down because of brokers upgraded or downgraded .If you are looking to day trade, you might want to check out the following stocks. I usually throw these on my watch list and monitor with resistance & support levels.You can also check previous stocks to buy reports- Right Here.
Vanguard Health (VHS), CenterPoint Energy (CNP), Dell (DELL), Edwards Lifesciences (EW) , NYSE Euronext (NYX), JDSU (JDSU) and Concur (CNQR) were upgraded or downgraded by analysts.
Vanguard Health (VHS) downgraded to Market Perform from Outperform at Wells Fargo.Wells Fargo downgraded Vanguard Health Systems citing concerns the company's operational improvements will take longer due to a planned reduction in capital expenditures. The firm lowered its target range for shares to $10-$12 from $19-$21.
CenterPoint Energy (CNP) initiated with a Market Perform at Wells Fargo.Price target range $19-$20.
Dell (DELL) upgraded to Overweight from Underweight at JP Morgan.JP Morgan said it was shedding its long-held, cautious view on Dell as the company has almost completed its "revenue pruning." The firm believes Dell is near a positive inflection point and that its long-term earnings growth can approach 10%. Price target raised to $21 from $17.50
Edwards Lifesciences (EW) downgraded to Neutral from Outperform at Credit Suisse.Credit Suisse downgraded Edwards Lifesciences based on valuation. Price target raised to $90 from $81.
NYSE Euronext (NYX) downgraded to Market Perform from Outperform at BMO Capital.BMO Capital downgraded NYSE Euronext citing the failure of the Deutsche Borse deal and modest earnings power. Price target lowered to $30 from $35.
CenterPoint Energy (CNP) initiated with a Market Perform at Wells Fargo.Price target range $19-$20.
Dell (DELL) upgraded to Overweight from Underweight at JP Morgan.JP Morgan said it was shedding its long-held, cautious view on Dell as the company has almost completed its "revenue pruning." The firm believes Dell is near a positive inflection point and that its long-term earnings growth can approach 10%. Price target raised to $21 from $17.50
Edwards Lifesciences (EW) downgraded to Neutral from Outperform at Credit Suisse.Credit Suisse downgraded Edwards Lifesciences based on valuation. Price target raised to $90 from $81.
NYSE Euronext (NYX) downgraded to Market Perform from Outperform at BMO Capital.BMO Capital downgraded NYSE Euronext citing the failure of the Deutsche Borse deal and modest earnings power. Price target lowered to $30 from $35.
JDSU (JDSU) downgraded to Neutral from Buy at UBS.UBS downgraded JDSU citing valuation. Price target raised to $14.50 from $13.
Concur (CNQR) upgraded to Buy from Neutral at UBS.UBS upgraded Concur citing the strong Q1 report and guidance, abundant growth opportunities, increased distribution capacity, and potential as a M&A target. Price target raised to $66 from $48.
Concur (CNQR) upgraded to Buy from Neutral at UBS.UBS upgraded Concur citing the strong Q1 report and guidance, abundant growth opportunities, increased distribution capacity, and potential as a M&A target. Price target raised to $66 from $48.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
